SCHEMBL6964030

SCHEMBL6964030

O=c1oc(-c2ccccc2)cc(O)c1SCCCCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
POLB P06746 1/20 0.45
GPR84 Q9NQS5 5/20 0.44
FAAH O00519 3/20 0.40
CES1 P23141 1/20 0.40
ASAH1 Q13510 1/20 0.40
ABCB1 P08183 4/20 0.39
ALOX15 P16050 3/20 0.39
IGF1R P08069 1/20 0.39
MAPT P10636 3/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
TP53 P04637 2/20 0.39
CYP3A4 P08684 2/20 0.39
HPGD P15428 2/20 0.39
KMT2A Q03164 2/20 0.39
HSD17B10 Q99714 2/20 0.39
GABRP O00591 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6963458 0.96 SMN1; SMN2 (0.46) SMN1; SMN2L3MBTL1POLBGPR84FAAH
SCHEMBL6960622 0.92 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1POLBGPR84ABCB1
SCHEMBL6965496 0.90 ASAH1 (0.41) SMN1; SMN2L3MBTL1POLBGPR84FAAH
SCHEMBL6954657 0.87 SMN1; SMN2 (0.44) SMN1; SMN2L3MBTL1POLBGPR84ABCB1
SCHEMBL6956148 0.86 PTGES (0.45) SMN1; SMN2L3MBTL1POLBGPR84FAAH
SCHEMBL6959678 0.85 SMN1; SMN2 (0.42) SMN1; SMN2L3MBTL1POLBGPR84FAAH
SCHEMBL6950945 0.84 GSK3B (0.47) SMN1; SMN2L3MBTL1POLBGPR84FAAH
SCHEMBL6964247 0.84 AR (0.42) SMN1; SMN2L3MBTL1POLBGPR84ASAH1
SCHEMBL6958378 0.84 MAOA (0.45) ABCB1XDHMAOAMAOB
SCHEMBL6960159 0.83 SMN1; SMN2 (0.40) SMN1; SMN2L3MBTL1POLBGPR84ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed